Keyphrases
Antitumor Effect
16%
Arginine
16%
B-cell Lymphoma 2 (Bcl-2)
16%
Chemoprevention
16%
Disease Stage
16%
Drug-like
16%
Early Melanoma
16%
High-risk Individuals
16%
Highly Selective
16%
Human Melanoma
100%
Human Melanoma Cells
16%
Human Skin
16%
In Vitro Study
16%
Invasion Potential
33%
JunD
16%
Knockdown
16%
Matrix metalloproteinase-1 (MMP-1)
16%
Melanocytes
33%
Melanoma
83%
Melanoma Cells
16%
Melanoma Progression
33%
Metastasis
16%
Neural Crest
16%
Neuronal Nitric Oxide Synthase (nNOS)
100%
Neuronal Nitric Oxide Synthase Inhibitor
100%
Nitric Oxide
50%
Nitric Oxide Inhibition
16%
Nitric Oxide Production
33%
Nitric Oxide Signaling
100%
Overgrowth
16%
Overproduction
16%
Oxide Stress
16%
Promising Strategies
16%
Redox Signaling
16%
Selective Neuronal Nitric Oxide Synthase Inhibitors
16%
Three-dimensional (3D)
16%
Medicine and Dentistry
Arginine
9%
Biopsy
9%
Chemoprophylaxis
9%
Diseases
9%
In Vitro
9%
Interstitial Collagenase
9%
Melanocyte
18%
Melanoma Cell
18%
Metastatic Carcinoma
9%
Neural Crest
9%
Neuronal Nitric Oxide Synthase
100%
Nitric Oxide
100%
Nitric Oxide Synthase Inhibitor
100%
Nodular Melanoma
100%
Ultraviolet Radiation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Arginine
9%
Disease
9%
Interstitial Collagenase
9%
Melanoma
100%
Neuronal Nitric Oxide Synthase
100%
Nitric Oxide
100%
Nitric Oxide Synthase Inhibitor
100%
Ultraviolet Radiation
9%